In breast cancer, the expression and function of JAM-A are complicated, as there are articles showing that the invasion ability is enhanced after JAM-A reduction [45,46], while most reports are in agreement with our results that high expression of JAM-A promotes the migration and development of breast cancer cells and is related to poorer prognosis [27,47,48,49,50]. This evidence concerns the gene F11R and breast cancer.